RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS

RETRACTABLE TECHNOLOGIES INC (RVP) filed an SEC Form 8-K — Other Events. Exhibit 99 RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, September 30, 2026 — Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has decla

Event · Dividend
Per share
$39,050.00
Kind
regular
Frequency
quarterly
Record date
October 12, 2026
Payable
October 22, 2026

Facts are quoted from the filing text and checked against it.

Original reporting
Published Sep 30, 2026, 5:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 5:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$RVP
Neutral
high confidence
Mentioned
$RVP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RVPNeutralLow
01

Why it matters

The dividend adds a small cash return for preferred shareholders and may cause a brief price uptick, but the overall market impact is limited.

02

Market read

A niche corporate action with modest price relevance for RVP shareholders; negligible broader market effect.

03

What to watch

Potential tax treatment of preferred dividends and the impact of upcoming earnings could outweigh the dividend effect.

Relevance 5/10Novelty 6/10Timing: announcement today, dividend payable Oct 22 2026

Background

Retractable Technologies manufactures safety medical devices such as retractable‑needle syringes. The 8‑K filing announces cash dividends for two series of convertible preferred stock.

Company-level read

Ticker impact

$RVPNeutralHigh confidence
Context

Retractable Technologies declared cash dividends for its Series II and III Class B convertible preferred shares, payable Oct 22 2026.

Expected impact

modest positive pressure as the market prices in the newly announced dividend

Evidence & confidence

Dividends are a tangible cash benefit; the amounts are small but represent the first payout for the preferred series, likely prompting a short‑term price bump.

Market effects

Limited impact on the broader medical device sector; dividend signals cash flow stability.

Minimal effect on U.S. markets; only relevant to investors holding RVP.

Low global relevance; the news is company‑specific.

Counterpoint

Investors may view the modest dividend as a sign that growth opportunities are limited, prompting a sell.

Key entities

  • Retractable Technologies, Inc.

    Medical device maker listed on NYSE American (ticker RVP).

Related articles

$SPGIMed

S&P Global prices $2 billion senior notes offering

S&P Global (SPGI) priced a $2 billion senior notes offering in three tranches, with yields ranging from 5.635% to 6.001%. The notes are due 2031, 2034, and 2036, and proceeds will be used for general corporate purposes. The offering is expected to close around November 18, 2026, and is managed by several major financial institutions. The notes will be unsecured obligations of the company, guaranteed by a subsidiary.

$SPGIMed

S&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036

S&P Global (NYSE: SPGI) priced a public offering of $750M, $600M, and $650M in senior notes due 2031, 2034, and 2036, respectively. The notes were priced at yields of 5.635%, 5.814%, and 6.001%. Proceeds will be used for general corporate purposes, including possible acquisitions or debt repayment. The offering is expected to close on November 18, 2026, subject to conditions.